Commentary: Bleeding Ulcers, Interaction Between NSAIDs and Helicobacter pylori Infection, and Nonulcer Dyspepsia
References (32)
- et al.
Eradication of H. pylori reduces the possibility of rebleeding in peptic ulcer disease
Gastrointest Endosc
(1995) - et al.
H. pylori eradication reduces the risk of rebleeding in ulcer hemorrhage
Gastrointest Endosc
(1995) - et al.
Ulcer risk factors: interactions between H. pylori infection, nonsteroidal use, and age
Am J Med
(1993) - et al.
Nitrofurans in the treatment of gastritis associated with Campylobacter pylori
Gastroenterology
(1988) - et al.
The effect of eradication of Helicobacter pylori on symptoms of non-ulcer dyspepsia (NUD): a randomized double-blind placebo controlled trial (abstr)
Gastroenterology
(1995) - et al.
Helicobacter pylori-negative duodenal ulcer
Am J Gastroenterol
(1991) - et al.
NSAID-associated gastric ulcers do not require H. pylori for their development
Am J Gastroenterol
(1992) - et al.
A study of the pathogenesis of Helicobacter pylori-negative chronic duodenal ulceration
Gut
(1993) - et al.
The problem ulcer: bleeding, perforation, H. pylori-negativity and intractability
- et al.
Randomised controlled trial of short-term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer
BMJ
(1992)
The prevalence of H. pylori and NSAID use in patients with severe UGI hemorrhage and their potential role in recurrence of ulcer bleeding (abstr)
Gastroenterology
(1992)
Bleeding ulcers have high false-negative rates for antral H. pylori when tested with urease test (abstr)
Gastroenterology
(1996)
Treatment of H. pylori reduces the rate of rebleeding in peptic ulcer disease
Scand J Gastroenterol
(1993)
Role of H. pylori eradication in the prevention of peptic ulcer bleeding relapse
Digestion
(1994)
A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer
N Engl J Med
(1994)
H. pylori eradication or maintenance H2-blockade in preventing recurrent ulcer bleeding (abstr)
Gastroenterology
(1996)
Cited by (7)
Nonsteroidal anti-inflammatory drug-induced acute gastric injury in Helicobacter pylori gastritis in Mongolian gerbils
2000, European Journal of PharmacologySurgical treatment of complicated duodenal ulcers: Controlled trials
2000, World Journal of SurgeryHelicobacteriose: Update 1999
1999, Leber Magen DarmPeptic ulcer bleeding: Interaction between non-steroidal anti- inflammatory drugs, Helicobacter pylori infection, and the ABO blood group system
1999, Scandinavian Journal of GastroenterologyNew aspects of treatment and prophylaxis of gastrointestinal side effects caused by nonsteroidal-antiinflammatory drugs (NSAIDs)
1999, Zeitschrift fur Rheumatologie
- b
Dr. Veldhuyzen van Zanten holds a Career Award from the Pharmaceutical Manufacturers Association of Canada/Medical Research Council.
- c
Dr. Veldhuyzen van Zanten has been involved in clinical studies sponsored by Abbot Laboratories, Alimenterics, Astra Pharma, Axcan, Glaxo Wellcome, and Tap Pharmaceuticals and has written a teaching program for Janssen and a Website page for Astra. No conflict of interest exists with the content of this article, and no financial endorsement was received for writing it.
Copyright © 1997 American Gastroenterological Association. Published by Elsevier Inc. All rights reserved.